Astal Laboratories Ltd to Raise ₹300 Crore for USFDA Pharma Unit Acquisitions
Astal Laboratories Ltd (512600) announces a ₹300 Crore fund raise via private placement and a strategic mandate to acquire USFDA or EU-GMP compliant units in India.
ALFA News
Straight from the exchange filing
Astal Laboratories Ltd (512600) announces a ₹300 Crore fund raise via private placement and a strategic mandate to acquire USFDA or EU-GMP compliant units in India.